The aim of present study was to clarify the role of the peroxisome proliferator-activated receptor (PPAR)γ Pro12Ala and C161T polymorphisms in the pathogenesis of polycystic ovary syndrome (PCOS) and their influenceon lipid and lipoprotein profiles of patients. This evidence concerns the gene PPARG and polycystic ovary syndrome.